BioInvent International AB (publ) (BOVNF)
USD 4.7
(0.0%)
USD 4.7
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 71.46 Million SEK | -77.35% |
| 2022 | 31.14 Million USD | 1359.35% |
| 2021 | 2.13 Million USD | -88.11% |
| 2020 | 17.94 Million USD | 79.27% |
| 2019 | 10 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 1.25 Million USD | 176.82% |
| 2024 Q1 | 554.98 Thousand SEK | -61.21% |
| 2024 Q2 | 4.61 Million SEK | -22.4% |
| 2023 Q1 | 1.55 Million USD | -20.94% |
| 2023 Q4 | 1.51 Million USD | -38.13% |
| 2023 FY | 7.05 Million USD | -77.35% |
| 2023 Q3 | 2.44 Million USD | 102.2% |
| 2023 Q2 | 1.2 Million USD | -22.44% |
| 2022 Q2 | 26.38 Million USD | 0.0% |
| 2022 FY | 31.14 Million USD | 1359.35% |
| 2022 Q4 | 1.97 Million USD | 22.63% |
| 2022 Q3 | 1.6 Million USD | -93.91% |
| 2021 FY | 2.13 Million USD | -88.11% |
| 2020 FY | 17.94 Million USD | 79.27% |
| 2019 FY | 10 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Bioxytran, Inc. | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | 15.77 Million USD | -353.059% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 21.47 Million USD | -232.717% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -108622.31% |
| Evofem Biosciences, Inc. | 18.21 Million USD | -292.255% |
| Santhera Pharmaceuticals Holding AG | 122.95 Million USD | 41.88% |
| Propanc Biopharma, Inc. | - USD | -Infinity% |
| Marizyme, Inc. | 645.81 Thousand USD | -10965.329% |
| Genus plc | 668.8 Million USD | 89.315% |
| Pharming Group N.V. | 245.31 Million USD | 70.87% |
| Therapeutic Solutions International, Inc. | 98.99 Thousand USD | -72087.203% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -17322.501% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| ContraFect Corporation | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -92995.452% |
| IMV Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 39.51 Thousand USD | -180731.52% |
| ONE Bio Corp. | 52.29 Million USD | -36.647% |
| RVL Pharmaceuticals plc | 49.72 Million USD | -43.724% |
| Mesoblast Limited | 5.9 Million USD | -1110.793% |
| MultiCell Technologies, Inc. | 49.32 USD | -144892438.524% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 29.59 Million USD | -141.447% |
| Genscript Biotech Corporation | 839.52 Million USD | 91.488% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Nanobac Pharmaceuticals, Incorporated | 17.62 Thousand USD | -405444.521% |
| Biomind Labs Inc. | - USD | -Infinity% |
| Provectus Biopharmaceuticals, Inc. | 557.71 Thousand USD | -12713.29% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -101987.143% |
| Skye Bioscience, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 75.72 Thousand USD | -94270.345% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 658.5 Thousand USD | -10752.088% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -146037.014% |
| Q BioMed Inc. | 284.35 Thousand USD | -25031.175% |
| GB Sciences, Inc. | - USD | -Infinity% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| CSL Limited | 14.69 Billion USD | 99.514% |
| Agentix Corp. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 145.09 Million USD | 50.75% |
| Enzolytics Inc. | 52.79 Thousand USD | -135253.057% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 608.52 Thousand USD | -11643.314% |
| MetaStat, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | 94.173% |
| Northwest Biotherapeutics, Inc. | 1.93 Million USD | -3598.81% |
| HST Global, Inc. | - USD | -Infinity% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | 999.00 USD | -7153153.253% |
| Endonovo Therapeutics, Inc. | 140.24 Thousand USD | -50855.491% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -11474.806% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 997.72 Thousand USD | -7062.387% |
| Capstone Therapeutics Corp. | 48.35 Million USD | -47.787% |
| Kadimastem Ltd | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 16.68 Million USD | -328.284% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -30108.404% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -30108.404% |
| Affymax, Inc. | 1.36 Million USD | -5119.942% |
| Mobile Lads Corp. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| International Stem Cell Corporation | 7.78 Million USD | -817.461% |
| CytoDyn Inc. | - USD | -Infinity% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 473.73 Thousand USD | -14984.753% |
| SYBLEU INC | 11.69 Thousand USD | -610886.662% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 13 Thousand USD | -549600.0% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | - USD | -Infinity% |
| Neutra Corp. | 39.53 Thousand USD | -180658.335% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -2045.976% |
| Coeptis Therapeutics, Inc. | - USD | -Infinity% |
| IXICO plc | 6.66 Million USD | -972.183% |
| IntelGenx Technologies Corp. | 1.03 Million USD | -6777.863% |
| Gelesis Holdings, Inc. | 25.76 Million USD | -177.335% |
| CSL Limited | 14.8 Billion USD | 99.517% |
| Cellectis S.A. | 755 Thousand USD | -9365.033% |